InsiderClue
Insiders · Profile

Chin Mark

Former Director at Pyxis Oncology · Director at Enliven Therapeutics. Filing since 16 Mar 2020. CIK 0001734389

PYXS Pyxis Oncology, Inc. Former Director · 2 trades ELVN Enliven Therapeutics, Inc. Director · 2 trades
Company
Date
Role
Action
Shares
Amount
Of holding
PYXS Pyxis Oncology, Inc.
21 Apr 2022
Former Director
Sold, plan not stated
1,745,761
$5.32M
100%
PYXS Pyxis Oncology, Inc.
13 Oct 2021
Director
Bought
312,500
$5.00M
21.8%
ELVN Enliven Therapeutics, Inc.
16 Jul 2021
Director
Bought
1,333,333
$8.00M
132%
ELVN Enliven Therapeutics, Inc.
16 Mar 2020
Director
Bought
187,500
$3.00M
13.7%
4 decisions on file.